| 1 |
33890551 | Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics. | 2021 Apr 23 |
2 |
| 2 |
34771669 | Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. | 2021 Nov 2 |
1 |
| 3 |
30935795 | Selective degradation of CDK6 by a palbociclib based PROTAC. | 2019 Jun 1 |
1 |
| 4 |
29108955 | Reduced state transition barrier of CDK6 from open to closed state induced by Thr177 phosphorylation and its implication in binding modes of inhibitors. | 2018 Mar |
1 |
| 5 |
29050219 | Preclinical characterization of abemaciclib in hormone receptor positive breast cancer. | 2017 Sep 19 |
1 |
| 6 |
11278443 | Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6. | 2001 May 18 |
1 |
| 7 |
9751050 | Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. | 1998 Sep 17 |
1 |